Abhishek Chatterjee

Dr. Abhishek Chatterjee is a Co-founder of BrickBio and a Professor of Chemistry at Boston College. He holds a degree from IIT Kharagpur and a Ph.D. from Cornell University. His groundbreaking research in chemical biology led to the development of technology for site-specific protein labeling, which forms the foundation of BrickBio's therapeutic platform.

BrickBio is a biotechnology company revolutionizing protein engineering with its site-specific conjugation platform. Utilizing technology developed by Dr. Abhishek Chatterjee, the company enables the incorporation of synthetic amino acids into proteins, creating novel biotherapeutics and antibody-drug conjugates. This precision engineering unlocks new possibilities for treating complex diseases.